Take the Chance
How to Become a UICC President
PATINA: Major FDA–EMA Divide Over Palbociclib in HER2+ Breast Cancer
What’s New On Radiotherapy of Lung Cancer in 2026?
Follicular Lymphoma: EHA 2026 Guidelines Move Chemotherapy-Free Combinations to First Relapse
The Promise on Hold: Takeda and Pfizer still to respond to help a Nigerian child with Hodgkin Lymphoma
PharmaMar as a Foundational Partner of OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
ALICE Trial at IGCS 2026: Reduced Surgical Morbidity in Endometrial Cancer Staging
The APPOS Charlotte 2026: Advanced Practice Providers Oncology Summit returns to Charlotte on March 6–7, 2026, bringing oncology clinicians together for a focused, two-day CE program dedicated to the latest advances […]
The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists […]
Pathology Update 2026 is the annual scientific conference hosted by The Royal College of Pathologists of Australia (RCPA). It will take place from March 6 to March 8, 2026, in Sydney, NSW. The meeting provides a multi-disciplinary pathology program for pathologists, scientists, and trainees, focusing on new developments and challenges in the field under the […]
The Best of the 19th St. Gallen International Breast Cancer Conference - India, incorporating the Asian Cancer Consensus Meet, is a premier scientific event scheduled for March 6-8, 2026, in Kolkata, India. Organized by the Institute of Breast Diseases, Kolkata, the conference will be held at Taj Taal Kutir and serves as the official regional […]
The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology. The meeting features tumor board–style case discussions across breast, gastrointestinal, genitourinary, hematologic, lymphoma, and thoracic cancers, led by faculty and expert panels from Stanford, UC Davis, […]
The ALRCaN Global webinar, titled “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS,” is scheduled for Friday, March 06, 2026, at 09:00 AM ET (06:00 PM Armenia Standard Time). Featuring Dr. Valentín Ortiz-Maldonado, the session will explore the clinical implementation and integration of […]
The Australian Precision Oncology Symposium 2026 (APOS 26) is a two-day scientific event focused on the theme "Mainstreaming Precision Oncology: Transforming Care Through Science, Medicine and Equity." Scheduled for March 6–7, 2026, in Sydney, the symposium serves as a collaborative platform for researchers, clinicians, and industry representatives to discuss the integration of genomic medicine into […]
The OPN Pacific Northwest Chapter Conference 2026 is a one-day regional summit organized by the Oncology Pharmacy Network, scheduled for March 7, 2026. The conference will be held at the Crowne Plaza in Portland, Oregon, United States. Designed for hematology/oncology pharmacy clinicians, including pharmacists and technicians, the event provides a platform to network, collaborate, and […]
The webinar "Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies" is a high-level clinical session scheduled for March 9, 2026, at 18:00 CET. Serving as the second installment of a specialized series by SPCC (Sharing Progress in Cancer Care), this activity moves beyond foundational knowledge to tackle the most debated aspects of MRD […]
The ELRIG Cell and Gene Therapy 2026 is a free-to-attend, two-day scientific conference scheduled for March 9–10, 2026, in Cambridge, UK. Organized by the European Laboratory Research and Innovation Group (ELRIG), this event focuses on the translational journey of advanced therapies from preclinical innovation to clinical application. The technical program features four key tracks: gene […]
The 2026 NCODA Global Oncology and Hematology Congress is a premier international gathering of oncology, hematology, and technology experts scheduled for March 11–12, 2026, in Dublin, Ireland. Organized by NCODA, the congress focuses on "bridging innovation and patient-centered care" through collaborative sessions that highlight best practices in medically integrated oncology. The technical program is designed […]
The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at […]
"The Role of Liquid Biopsy in the Characterization of Predictive Markers of Response in Patients with Lung Cancer" is a specialized medical conference scheduled for March 12, 2026, in Bari, Italy. This educational event is designed specifically for healthcare professionals - including Pathologists, Oncologists, Biologists, and Laboratory Technicians - to explore advanced diagnostic techniques that […]
The 12th ImmunoTherapy of Cancer Conference (ITOC12) is a European meeting scheduled to take place from March 12 – 14, 2026, in Munich, Germany. The conference provides a global platform focused on translational research in immuno-oncology, serving as a forum for the discussion of early clinical translation and its unique challenges. Organized by WMA GmbH […]
The 10th ESO SIOPE Masterclass in Paediatric Oncology is scheduled on March 12-15, 2026, with the first block delivered online and the second block held in Barcelona, Spain. It offers state-of-the-art plenary lectures, interactive workshops, tumor board simulations, and case-based discussions with expert feedback. The program is aimed at enhancing clinical management skills in childhood […]
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment […]
